Respecta® Balance Gel* (MD)

For vaginal health and balance.

Product background

Respecta® Balance Gel is a medical device adjuvant in the treatment of vaginitis and vaginosis specifically studied for rebalancing the physiological pH and vaginal microbiota.
The vaginal environment is populated by numerous bacterial species (such as lactobacilli, gardnerella, streptococci, etc.) that in physiological conditions are in balance (eubiosis) with a clear prevalence of lactobacilli. However, this fine balance can be altered by several factors including antibiotic consumption, use of overly aggressive cleansers, irritative or allergic conditions. Consequently, potentially pathogenic microorganisms such as Candida and Gardnerella take over the Lactobacillus population, creating a state of dysbiosis up to causing pathological conditions such as bacterial vaginosis, aerobic vaginitis or vulva-vaginitis caused by Candida spp. (VVC). In particular, in case of dysbiosis, vaginal pH often increases creating a vicious circle with a progressive reduction of the defenses of the vaginal mucosa.

Respecta® Balance Gel is suitable for restoring the physiological vaginal pH, favoring the proliferation and growth of beneficial microorganisms (lactobacilli) that normally colonize healthy tissue.

Key ingredients

Glycogen, prebiotic fiber, hyaluronic acid and lactic acid.


  • Vaginal dysbiosis
  • Bacterial and yeast infections

Benefits and features

  • Restores physiological vaginal pH
  • Promotes the growth of beneficial microorganism
  • Provides hydration and protection to the vaginal tissue
  • Promotes the formation of protective biofilm
  • Works well in combination with standard oral drug/probiotic treatment

Scientific evidence and proprietary studies

In vitro mechanistic study.

*Registered as “Respecta® Gel Vaginale (NB 0476)”.


Product name Respecta® Balance Gel*
Status Medical device class IIa
Key ingredients Glycogen, prebiotic fiber, hyaluronic acid and lactic acid
Target and indication Adjuvant in the treatment of vaginitis and vaginosis
Claims EFSA n. a.
Scientific evidence and study Mechanistic study
Pharmaceutical form Gel (single-use tubes or tube with vaginal applicator)

Are you interested in this product?

We respond to any technical or commercial request:


Stay updated on news

* indicates required